Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Application
Item No. 32984

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Taurolithocholic acid-d4 (TLCA-d4) is intended for use as an internal standard for the quantification of TLCA (Item No. 17275) by GC- or LC-MS. TLCA is a taurine-conjugated form of the secondary bile acid lithocholic acid (Item No. 20253).1 TLCA (75 μM) increases caspase-3 and -7 activity in Hep3B cells transfected with sodium taurocholate cotransporting peptide (NTCP), but not nontransfected Hep3B cells.2 It has been used to induce cholestasis in ex vivo and in vivo animal models of hepatocellular cholestasis.3,4 Serum levels of TLCA increase approximately 5-fold within two hours during an oral lipid tolerance test in humans.1
WARNING This product is not for human or veterinary use.
1. Bile acid metabolome after an oral lipid tolerance test by liquid chromatography-
2. Bile acid-
3. Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-
4. Cholestasis in rats induced by taurolithocholate. Nature 210(5042), 1262-1263 (1966).